Skip to main content

Advertisement

Log in

IL-8-251A>T polymorphism is associated with breast cancer risk: a meta-analysis

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Objective

IL-8-251A>T polymorphisms have been reported to influence the risk for breast cancer in many studies; however, the results still remain controversial and ambiguous. The aim of this study was to determine more precise estimations for the relationship between IL-8-251A>T polymorphisms and the risk for breast cancer.

Methods

Electronic searches for all publications were conducted on association between this variant and breast cancer in several databases through November 2010. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of the association. Six studies were identified, including 1,880 breast cancer patients and 2,013 controls.

Results

Overall, no significant associations between IL-8-251A>T polymorphism and breast cancer (codominant model: TA vs. AA OR = 1.075, 95%CI = 0.864–1.337; TT vs. AA, OR = 0.900, 95%CI = 0.598–1.354; dominant model: OR = 1.011, 95%CI = 0.783–1.304; and recessive model: OR = 0.854, 95%CI = 0.623–1.171). In the subgroup analysis by ethnicity, significantly decreased risk was found for Africans (TT vs. AA OR = 0.541; 95%CI = 0.396–0.741; dominant model: OR = 0.737, 95%CI = 0.570–0.953; recessive model: OR = 0.594; 95%CI = 0.459–0.768). In the stratified analysis by control sources, significant association was observed in population-based studies (recessive model: OR = 0.692; 95%CI = 0.566–0.861).

Conclusions

This meta-analysis suggests the IL-8-251A/T polymorphism is associated with breast cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129

    Article  Google Scholar 

  • De Jong MM, Nolte IM, Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, Schaapveld M, de Vries EG (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225–242

    Article  PubMed  Google Scholar 

  • DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  • Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration and John Wiley

  • Hull J, Thomson A, Kwiatkowski D (2000) Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55:1023–1027

    Article  PubMed  CAS  Google Scholar 

  • Kamali-Sarvestani E, Aliparasti MR, Atefi S (2007) Association of interleukin-8 (IL-8 or CXCL8) −251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer. Neoplasma 54:484–489

    PubMed  CAS  Google Scholar 

  • Liu JY, Zhai XJ, Jin GF et al (2007) A study of relationship between polymorphisms of interleukin-8 and risk of breast cancer in Chinese population. China Cancer 16:8–10

    CAS  Google Scholar 

  • Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  • Mukaida N, Shiroo M, Matsushima K (1989) Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143:1366–1371

    PubMed  CAS  Google Scholar 

  • Ohyauchi M, Imatani A, Yonechi M et al (2005) The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54:330–335

    Article  PubMed  CAS  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  • Ponder BA (2001) Cancer genetics. Nature 411:336–341

    Article  PubMed  CAS  Google Scholar 

  • Smith KC, Bateman AC, Fussell HM, Howell WM (2004) Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immuno genet 31:167–173

    Article  CAS  Google Scholar 

  • Snoussi K, Mahfoudh W, Bouaouina N et al (2006) Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 67:13–21

    Article  PubMed  CAS  Google Scholar 

  • Snoussi K, Mahfoudh W, Bouaouina N et al (2010) Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 10:283

    Article  PubMed  Google Scholar 

  • Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y (2005) Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14:2487–2493

    Article  PubMed  CAS  Google Scholar 

  • Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291–1306

    Article  PubMed  Google Scholar 

  • Vogel U, Christensen J, Nexo BA et al (2007) Peroxisome proliferator-activated receptor-gamma2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 28:427–434

    Article  PubMed  CAS  Google Scholar 

  • Weber BL, Nathanson KL (2000) Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 36:1193–1199

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qiang Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, Q., Wang, C., Qiu, LJ. et al. IL-8-251A>T polymorphism is associated with breast cancer risk: a meta-analysis. J Cancer Res Clin Oncol 137, 1147–1150 (2011). https://doi.org/10.1007/s00432-011-0981-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-011-0981-5

Keywords

Navigation